Project Grant HT94252510205
Award Date
4/1/25
Completion Date
3/31/29
Dollars Obligated
$2.9M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports...
The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...
This $630,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports The Ohio State University's research to develop a targeted antibody and immunotoxin combination therapy to improve treatment of T-cell lymphoma. The award period is from July 15, 2023 to July 14, 2025. This research aims to transform health care for Service Members and the American public through innovative and impactful medical solutions for the...
The Defense Health Agency awarded The Ohio State University a $8,375,496 cooperative agreement under the Military Medical Research and Development program (CFDA 12.420) from September 30, 2022 to September 29, 2026. This award will fund the Augmenting Suicide Prevention Interventions for Service Members project, which consists of five synergistic studies that aim to identify the strategies, delivery methods, providers, and circumstances most effective for preventing suicidality among military...
This $249,960 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Ohio State University to investigate the effects of the aged inflammatory central nervous system (CNS) microenvironment on oligodendroglial properties and remyelination capacity. The research aims to advance scientific understanding of age-related changes in the CNS that can impact myelin repair, with potential applications for...
The U.S. Defense Health Agency awarded a $1,225,245 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiovascular Risk Profiling of Deployment-Related Respiratory Disease: A Translational Approach". The grant will fund a 3-year research project from November 1, 2024 to October 31, 2027 focused on investigating medical solutions for addressing cardiovascular conditions associated with...
The Department of the Army Medical Command awarded a $796,587 Project Grant to The Ohio State University Office of Sponsored Programs through the Military Medical Research and Development program. The grant will fund the PROMOTING RESIDENTS' EXCELLENCE IN PATIENT-CENTERED CARE (PREPARE) FOR AUTISTIC ADULTS project from September 30, 2022 to September 29, 2025.
The PREPARE project aims to transform healthcare for autistic adults through innovative research and solutions. The Ohio State...
The U.S. Defense Health Agency has awarded a $1,181,250 Project Grant to The Ohio State University to conduct research on "MIF Inhibition and Glucocorticoid Therapeutics as Synergistic Treatment to Promote Neuronal Survival in Traumatic Retinal Injury" over the period from November 1, 2024 to October 31, 2027. This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports a range of biomedical research initiatives aimed at improving...
This federal Project Grant award of $267,311 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The award was made to The Ohio State University, which will serve as the prime recipient, with a performance period from August 1, 2024 to July 31, 2027. The project aims to...
This Project Grant award of $717,896.00 was provided by the Defense Health Agency to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420). The purpose of the award is to conduct research on prebiotic and probiotic interventions for the treatment of traumatic brain injury (TBI)-induced microbiome dysfunction. The Ohio State University is the prime awardee, and they have issued a $XXX,XXX subaward to the Research Institute at Nationwide Children's...